在慢性诱导性疹的主要亚型中揭示治疗反应预测因素

Sinem Ornek Ozdemir1, Pelin Kuteyla Can2, Ece Nur Degirmentepe3

  • 1Department of Dermatology, Health Sciences University, Ankara Training and Research Hospital, Ankara, Turkey, drsinemornek@yahoo.com.

概括

慢性诱导性疹 (CIndU) 对抗组胺剂 (AHs) 和奥马利祖马布 (omalizumab) 的反应良好. 疾病持续时间和血管等因素可以预测CIndU患者的AH治疗结果.

相关概念视频

Hypersensitivities01:30

Hypersensitivities

Hypersensitivity, also known as a hypersensitivity reaction or allergic reaction, is a condition where the body's immune system reacts abnormally to a foreign substance. Such substances, that cause hypersensitivity are referred to as an allergen, could be something typically harmless to most people, like pollen or certain foods.
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
586
Allergic Drug Reactions01:27

Allergic Drug Reactions

Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
833
Allergic Reactions02:06

Allergic Reactions

Overview
27.3K